A Registry Study of Biomarkers in Progression of Acute Heart Failure(BIOMS-POAHF)

NCT04108182 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 850

Last updated 2019-09-30

No results posted yet for this study

Summary

The registry study aims to discover the prognostic value of bio-markers in acute heart failure

Conditions

Sponsors & Collaborators

  • Beijing Institute of Heart, Lung and Blood Vessel Diseases

    lead OTHER

Principal Investigators

  • Jie Du, PHD · Beijing Anzhen Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2025-08-31
Completion
2025-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04108182 on ClinicalTrials.gov